Buy YK-11 10mg x30 Capsules

YK-11 is a steroidal SARM that operates through a mechanism distinct from all other SARMs: it inhibits myostatin by inducing expression of follistatin in muscle cells. Myostatin is a negative regulator of muscle growth that establishes the genetic ceiling on muscle mass — individuals with myostatin mutations or knockout naturally develop extreme muscularity. YK-11 pharmacologically mimics this effect.

▸The Myostatin-Follistatin Axis

Myostatin (GDF-8) is a TGF-beta family member secreted by muscle cells that limits hypertrophy through SMAD2/3 signaling. Follistatin is the endogenous antagonist — it binds and neutralizes myostatin, allowing unrestricted muscle growth. YK-11 induces follistatin expression via androgen receptor activation, effectively creating a temporary myostatin-deficient state.

▸Unique SARM Profile

Unlike non-steroidal SARMs (LGD, RAD, Ostarine), YK-11's steroidal structure gives it a different activity profile with stronger androgen receptor activation in some tissues. It produces larger lean mass gains than non-steroidal SARMs in some user populations — at the cost of stronger suppression and a less clean hormonal profile. PCT is essential.

▸Research Limitations

YK-11 has less clinical data than Ostarine or LGD-4033. Animal and in vitro data are available; no controlled human trials have been published. The anecdotal body of evidence from users is extensive but lacks the clinical validation of the more-studied SARMs. This places it in a higher-risk, higher-reward tier for informed users.